Floatz logo

Valaciclovir

Hepatocellular Carcinoma

Huazhong University of Science and TechnologySmall moleculePhase 3Dormant
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
65/ 100

Competitive context

263 Active assets in the Hepatocellular Carcinoma cohort.

Asset / SponsorPhaseRating
Theprubicin
RWTH Aachen University
Phase 4BB
Ethiodized Oil
RWTH Aachen University
Phase 4BB
Eloxatin
Li Qiang
Phase 4BB
Calcium folinate pentahydrate
Li Qiang
Phase 4BB
FLUOROURACILUM
Li Qiang
Phase 4BB

View all 50 →

Same molecule, other indications

Valaciclovir is also rated in:

herpes simplex infectious diseaseDormant
BBB
Indicative ·
74 / 100
View asset →
schizoaffective disorderDormant
BB
Indicative ·
68 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →